Olopatadine Eye Drops 0.7% (Olopatadine Hydrochloride) (Single Use), Olopatadine Eye Drops 0.7% (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 7.76mg
Eye drops · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
MFDS item code 201804616 · Approved 2018.11.21 · Insurance code 643508071,643509031
Relief of allergic conjunctivitis (eye itching)
Eye itching caused by allergic conjunctivitis requires appropriate treatment to reduce inflammation and discomfort of the eyes. This medicine alleviates allergic reactions and reduces itching and swelling of the eyes, improving symptoms. Moreover, it relieves eye redness and alleviates uncomfortable symptoms, aiding in daily life. This treatment process enables rapid recovery and continuous symptom management. Therefore, it is used for the treatment of eye itching associated with allergic conjunctivitis.
Instill 1 drop once a day.
This medication should not be used by patients who are allergic to the active ingredient or any of the components of this medication. When using this medication, vision may be blurred or the eyes may become dry, and in rare cases, damage to the cornea may occur, so caution is advised. If wearing contact lenses, it is recommended not to use them, especially when the eyes are red, and to wait at least 5 minutes after instillation before wearing them. This medication is a non-sedating antihistamine, but it may temporarily blur vision after administration, so one should wait until vision is clear before driving or operating machinery. Patients receiving long-term steroid treatment should gradually reduce the steroid dose according to their doctor’s instructions when using this medication. It is advisable for patients with seasonal allergies to start using this medication before the symptoms begin and to continue until the symptoms resolve. If no effect is observed, it is safe not to use the medication for long periods. This medication is an eye drop intended for use on the eyes only and should not be used by injection or orally. During pregnancy, it should only be used if absolutely necessary, considering the potential risks to the fetus, and during breastfeeding, the potential effects on the baby should be carefully assessed before use. The safety and efficacy in children under 2 years old have not been established, so it is preferable not to use it. Generally, the elderly can safely use this medication. When using the medication, avoid direct contact between the nozzle and the eye, use single-use products immediately after opening, and dispose of any remaining solution. Store this medication out of reach of children, away from direct sunlight, and in a cool place. For quality maintenance, it is recommended not to transfer to other containers. This medication is known not to pose a risk of carcinogenicity or mutagenicity and does not significantly affect reproductive function.
Blurry vision, dry eyes, epithelial punctate keratitis, abnormal sensations in the eyes, taste disturbances, cases of corneal calcification (very rarely reported)
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container that can block light and air, maintaining a temperature between 2 degrees Celsius and 25 degrees Celsius. Both multi-use and single-use products should be stored under the same conditions to maintain freshness and safety during use.
[Multi-use] Colorless or pale yellow transparent eye drops in an opaque white plastic container [Single use] Colorless or pale yellow transparent eye drops in a colorless transparent plastic container
2.5 milliliters/bottle, 12 tubes/box [0.5 milliliters/tube × 6 × 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 7.76mg
Eye drops · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.